Effectiveness of Early Intervention in Palliative Care for Acute Myeloid Leukemia Patients Comparing to Standard of Care
Launched by UNIVERSIDADE DO PORTO · Feb 21, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of early palliative care for patients with acute myeloid leukemia (AML). Palliative care focuses on improving quality of life by addressing physical and emotional symptoms like pain, anxiety, and fatigue, especially during intense treatments like chemotherapy. The goal is to see if starting this supportive care early can help patients manage their symptoms better and make more informed decisions about their treatment.
To participate in this trial, patients must be 70 years old or younger, capable of making their own healthcare decisions, and have a diagnosis of acute myeloid leukemia. They should also be receiving treatment at a specific hospital. Participants can expect to receive comprehensive support from a specialized team that will help manage their symptoms and improve their overall well-being. This trial aims to gather important information that could change how care is provided to AML patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Capable of making decisions
- • Diagnosed with acute myeloid leukemia
- • Aged 70 years or less
- • Treated or referred for treatment at the Hematology department of Centro Hospitalar e Universitário de São João.
- Exclusion Criteria:
- • All patients referred for "best supportive care", that is, for supportive care including treatment with cytoreductive intent.
About Universidade Do Porto
The Universidade do Porto, one of Portugal's leading academic institutions, is dedicated to advancing medical research and innovation through its clinical trial sponsorship. With a robust framework for interdisciplinary collaboration, the university fosters an environment that encourages the exploration of cutting-edge therapies and healthcare solutions. Leveraging its extensive network of researchers, clinical practitioners, and state-of-the-art facilities, the Universidade do Porto is committed to conducting high-quality, ethical clinical trials aimed at improving patient outcomes and contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto, , Portugal
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported